Konukiewitz, B.; Kasajima, A.; Schmitt, M.; Schwamborn, K.; Groll, T.; Schicktanz, F.; Delbridge, C.; Schütze, L.M.; Wilhelm, D.; Lang, C.;
et al. Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker? Cancers 2021, 13, 5111.
https://doi.org/10.3390/cancers13205111
AMA Style
Konukiewitz B, Kasajima A, Schmitt M, Schwamborn K, Groll T, Schicktanz F, Delbridge C, Schütze LM, Wilhelm D, Lang C,
et al. Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker? Cancers. 2021; 13(20):5111.
https://doi.org/10.3390/cancers13205111
Chicago/Turabian Style
Konukiewitz, Björn, Atsuko Kasajima, Maxime Schmitt, Kristina Schwamborn, Tanja Groll, Felix Schicktanz, Claire Delbridge, Lisa Marie Schütze, Dirk Wilhelm, Corinna Lang,
and et al. 2021. "Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?" Cancers 13, no. 20: 5111.
https://doi.org/10.3390/cancers13205111
APA Style
Konukiewitz, B., Kasajima, A., Schmitt, M., Schwamborn, K., Groll, T., Schicktanz, F., Delbridge, C., Schütze, L. M., Wilhelm, D., Lang, C., Lange, S., Foersch, S., Jank, P., Steiger, K., Werder, A. v., Denkert, C., Weichert, W., Klöppel, G., & Jesinghaus, M.
(2021). Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker? Cancers, 13(20), 5111.
https://doi.org/10.3390/cancers13205111